Using these gene markers [mam, CEA, CK19, PIP, muc1, PSE, Erb (BM only) and EpCAM (PBL only)] we analyzed 215 PBL samples and 177 BM samples from patients with T1-T3 primary breast cancer without clinical evidence of metastatic disease. This evidence concerns the gene ESR2 and metastatic neoplasm.